screened synergistic effects of a glutaminase inhibitor and a library of 292 anti‐cancer compounds.[7] Lately, multi‐omics data of 54 cancer cell lines involving metabolomics analysis were used to correlate transcriptional regulation of tumor growth with metabolism.[8] Anglada‐Girotto et al. This evidence concerns the gene GLS and cancer.